S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

CRDL Cardiol Therapeutics Inc

1.19

-0.02 (-1.65%)

Jan 17 2025 - Closed

Delayed by 15 minutes

Orphan Drug Designation Sends Shares of this Dual-Listed Life Science Therapy Company Soaring

Orphan drug designation, or ODD, is valuable on both a humanitarian and a profitability basis. And this company is seeing shares rally following news that it was granted the designation for the...

To read the full story on AllPennyStocks.com, click here.

Cardiol Therapeutics (NASDAQ:CRDL)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Cardiol Therapeutics Charts.

Cardiol Therapeutics (NASDAQ:CRDL)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Cardiol Therapeutics Charts.

Cardiol Therapeutics Inc News

PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx™ Addressing Patients with Recurrent Pericarditis
Thursday 19 December 2024 (4 weeks ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 18 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index
Wednesday 13 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 22 October 2024 (3 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 11 October 2024 (3 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 10 October 2024 (3 months ago) • Edgar (US Regulatory)

Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)]
Wednesday 9 October 2024 (3 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 9 October 2024 (3 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 8 October 2024 (3 months ago) • Edgar (US Regulatory)

Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)]
Tuesday 8 October 2024 (3 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 24 September 2024 (4 months ago) • Edgar (US Regulatory)

More Cardiol Therapeutics Inc News Articles

MineralRite (PK)

TheGlobe com (PK)

RespireRx Pharmaceuticals (CE)

UAV Corpoation (PK)

Good Vibrations Shoes (PK)

GBT Technologies (PK)

Bioelectronics (PK)

TPT Global Tech (CE)

Rennova Health (CE)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions